Searching the RRID Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
Protocol Name
DOI:DOI:10.17504/protocols.io.frjbm4n RRID Copied  
PDF Report How to cite
New England BioLabs,  Inc. 2016. Transfection of Cas9 RNP (ribonucleoprotein) into adherent cells using the Lipofectamine® RNAiMAX. protocols.io https://dx.doi.org/10.17504/protocols.io.frjbm4n
Copy Citation Copied
Protocol Information

URL: https://dx.doi.org/DOI:10.17504/protocols.io.frjbm4n

Authors: New England BioLabs, Inc.

Group: New England Biolabs (NEB)

Summary: Cas9 nuclease may be used in vivo to create targeted genome modifications.  There are several ways in which to introduce Cas9-guide RNA complexes into cells.  Here we present a method for the transfection of Cas9 RNP’s into HEK293 FT cells using Thermo Fisher Lipofectamine® RNAiMAX.  This is a ‘reverse transfection’ method that uses a final concentration of 10 nM RNP per transfection in a 96-well culture plate.

Affiliations: ,

External URL: https://www.neb.com/protocols/2016/07/26/transfection-of-cas9-rnp-ribonucleoprotein-into-adherent-cells-using-the-lipofectamine-rnaimax

Version: 1

Publication Date: 2016

Expand All
Usage and Citation Metrics

Coming soon.

Checkfor resource mentions.

Collaborator Network

Coming soon.

Data and Source Information

Source: